Production of De Novo Complement (C1q)-Fixing Donor Specific Antibodies Correlates with C4d Deposition in Kidney Transplant Recipients.

被引:0
|
作者
Yabu, Julie [1 ]
Chen, Ge [1 ]
Sequeira, Flavia [1 ]
Lou, Calvin [1 ]
Higgins, John [1 ]
Javaid, Basit [1 ]
Busque, Stephan [1 ]
Tyan, Dolly [1 ]
机构
[1] Stanford Univ, Palo Alto, CA 94304 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:238 / 238
页数:1
相关论文
共 50 条
  • [11] THE ROLE OF DE NOVO DQ DONOR SPECIFIC ANTIBODIES (DSA), IGG SUBCLASSES AND C1Q IN KIDNEY TRANSPLANT OUTCOME
    Freitas, Maria Cecilia
    Ozawa, Mikki
    Anh Nguyen
    Sasaki, Nori
    Everly, Matthew
    Rebellato, Lorita M.
    Terasaki, Paul I.
    HUMAN IMMUNOLOGY, 2013, 74 (05) : 485 - 485
  • [12] DE NOVO PRODUCTION OF C1Q-FIXING DONOR-SPECIFIC ANTIBODIES IS ASSOCIATED WITH KIDNEY ALLOGRAFT LOSS
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Caputo, Daniela
    Adorno, Domenico
    TRANSPLANT INTERNATIONAL, 2013, 26 : 62 - 62
  • [13] IDENTIFICATION AND CONSEQUENCES OF ANTIBODIES WHICH BOUND C1Q IN 118 KIDNEY TRANSPLANT RECIPIENTS WITH DONOR SPECIFIC ANTIBODIES
    Gautier, G.
    Caillard, S.
    Parissiadis, A.
    Olagne, J.
    Muller, C.
    Perrin, P.
    Braun, L.
    Heibel, F.
    Hanau, D.
    Moulin, B.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [14] Impact of C1q fixing donor-specific antibodies on renal transplant outcome
    Baranwal, Ajay Kumar
    Goswami, Sanjeev
    Agarwal, Sanjay Kumar
    Kaur, Gurvinder
    Mehra, Narinder Kumar
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (01)
  • [15] C1Q FIXING ABILITY OF DE NOVO DONOR SPECIFIC ANTIBODIES PREDICTS EARLY BUT NOT LONG-TERM KIDNEY ALLOGRAFT LOSS
    Guerville, F.
    Guidicelli, G. L.
    Lepreux, S.
    Merville, P.
    Taupin, J. L.
    Couzi, L.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 17 - 17
  • [16] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [17] ASSESSING THE CORRELATION BETWEEN C3D-BINDING DE NOVO DONOR SPECIFIC HLA ANTIBODIES AND REJECTION IN KIDNEY TRANSPLANT RECIPIENTS.
    Cusick, Matthew
    Haarberg, Kelley
    Friedewald, John
    Tambur, Anat R.
    HUMAN IMMUNOLOGY, 2015, 76 : 142 - 142
  • [18] POST KIDNEY TRANSPLANTATION MONITORING WITH C1Q FIXING HLA DONOR SPECIFIC ANTIBODIES
    Vittoraki, Angeliki G.
    Darema, Maria N.
    Ioannou, Sofia I.
    Markaki, Pavlina V.
    Tsakalos, Anastasios Ch.
    Apostolaki, Maria D.
    Boletis, John N.
    Iniotaki, Aliki G.
    HLA, 2016, 87 (04) : 245 - 245
  • [19] Impact of IgG Subclass and C1q Binding Donor-Specific HLA Antibodies on Antibody Mediated Rejection in Kidney Transplant Recipients.
    Lee, H.
    Ryu, J.
    Yun, S.
    Ban, T.
    Ko, E.
    Yang, C.
    Oh, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 653 - 653
  • [20] CLINICAL RISK STRATIFICATION OF PAEDIATRIC RENAL TRANSPLANT RECIPIENTS USING C1Q AND C3D FIXING OF DONOR SPECIFIC ANTIBODIES.
    Kim, J. J.
    Shaw, O.
    Martin, C.
    Michaelides, G.
    Balasubramaniam, R.
    Sebire, N. J.
    Mamode, N.
    Dorling, A.
    Vaughan, R.
    Marks, S. D.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 42 - 42